Storia in 8 fonti

Trump's generic drugs tariff threatens Indian pharma's top market

100% levy from 2028 could accelerate push into higher value medicines

Raccontata da

economictimes.indiatimes.com

hindustantimes.com

timesofindia.indiatimes.com

newsbytesapp.com

thehindubusinessline.com

theprint.in

asia.nikkei.com

scmp.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

asia.nikkei.comStai leggendo1 mese fa

Trump's generic drugs tariff threatens Indian pharma's top market

100% levy from 2028 could accelerate push into higher value medicines

originale

Timeline cronologica

mercoledì 22 luglio 2026·economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%
Trump ⁠has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.
mercoledì 22 luglio 2026·hindustantimes.com
US to impose steep tariffs on generic medicine imports from Aug 2028
US to impose steep tariffs on generic medicine imports from Aug 2028

economictimes.indiatimes.com

1 mese fa

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one hundred percent, eventually reaching two hundred percent by 2028. This strategy…

Leggi questa versione → originale

timesofindia.indiatimes.com1 mese fa

Pharma companies in a flux over Trump's 200% tariff move on generics

India's $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug 2028 and 200% a year later,…

Leggi questa versione → originale

hindustantimes.com1 mese fa

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. | India News

Leggi questa versione → originale

channelnewsasia.com1 mese fa

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

Analysts warn the levies could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies.

Leggi questa versione → originale

thehindubusinessline.com1 mese fa

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

Trump announces a tariff timeline for generic drugs, starting with zero tariffs for a year, then escalating to 200%.

Leggi questa versione → originale

mercoledì 22 luglio 2026·

hindustantimes.com

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. | India News

mercoledì 22 luglio 2026·

economictimes.indiatimes.com

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Indian pharma stocks are likely to remain in focus after US President Donald Trump announced a phased tariff plan for generic medicines, offering a two-year tariff exemption…

mercoledì 22 luglio 2026·

timesofindia.indiatimes.com

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

President Donald Trump on Wednesday announced a phased tariff plan for imported generic medicines, saying they would continue to enter US duty-free for the next two years before…

mercoledì 22 luglio 2026·

newsbytesapp.com

Trump threatens tariff on generic medicines: Should India be worried?

US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.

mercoledì 22 luglio 2026·

hindustantimes.com

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year. | India News

mercoledì 22 luglio 2026·

thehindubusinessline.com

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

Trump announces a tariff timeline for generic drugs, starting with zero tariffs for a year, then escalating to 200%.

mercoledì 22 luglio 2026·

theprint.in

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

US to impose no tariff on generic pharmaceutical goods initially, before hiking to 200%. Announcement set to impact India as US accounts for third of pharma exports from nation.

mercoledì 22 luglio 2026·

timesofindia.indiatimes.com

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Pharmaceutical stocks came under pressure on Wednesday after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, raising concerns over the…

mercoledì 22 luglio 2026·

economictimes.indiatimes.com

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufacturing and supply chain strategies. After…

mercoledì 22 luglio 2026·

economictimes.indiatimes.com

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one hundred percent, eventually reaching…

mercoledì 22 luglio 2026·

economictimes.indiatimes.com

Trump’s 100% generic drug duty threatens US low-cost supply

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move…

mercoledì 22 luglio 2026·

economictimes.indiatimes.com

200% Trump tariff shock? India’s cheap pills may still beat US rivals

US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical exporters, but the country's cost advantage…

mercoledì 22 luglio 2026·

economictimes.indiatimes.com

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say the long-term impact may be limited.…

mercoledì 22 luglio 2026·

economictimes.indiatimes.com

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

Donald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analysts believe the long-term impact could be…

mercoledì 22 luglio 2026·

timesofindia.indiatimes.com

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

In a blow to India’s pharmaceutical industry, the Donald Trump administration has announced up to 200% tariffs on generic drugs that will be applicable in the coming years.

mercoledì 22 luglio 2026·

thehindubusinessline.com

US proposal to impose steep tariffs on generic medicines could significantly impact India: GTRI

US tariffs on generic medicines may drastically affect India's pharmaceutical exports, particularly in higher-value formulations, warns GTRI.

mercoledì 22 luglio 2026·

asia.nikkei.com

Trump's generic drugs tariff threatens Indian pharma's top market

100% levy from 2028 could accelerate push into higher value medicines

mercoledì 22 luglio 2026·

scmp.com

What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?

Analysts say that China’s pivot from generics to innovative drugs means the industry is less exposed to US levies.

Trump's generic drugs tariff threatens Indian pharma's top market

Timeline cronologica

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

US to impose steep tariffs on generic medicine imports from Aug 2028

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Pharma companies in a flux over Trump's 200% tariff move on generics

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Trump threatens tariff on generic medicines: Should India be worried?

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

US proposal to impose steep tariffs on generic medicines could significantly impact India: GTRI

Trump's generic drugs tariff threatens Indian pharma's top market

What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?